These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1243225)

  • 1. Antisplenic tissue antibody in aplastic anemia.
    Yoda Y; Abe T; Komiya M
    Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):315-9. PubMed ID: 1243225
    [No Abstract]   [Full Text] [Related]  

  • 2. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia.
    Bailey FA; Lilly M; Bertoli LF; Ball GV
    Arthritis Rheum; 1989 Jul; 32(7):901-5. PubMed ID: 2751721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective red-cell aplasia. Report of 3 patients with studies of a circulating antibody against erythropoiesis].
    García Triana Y; Gudin IV; Callejas JR; Hernández P
    Sangre (Barc); 1983; 28(4):421-8. PubMed ID: 6658635
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leukocyte auto and iso-antibodies in bone marrow aplasias].
    Sgandurra A; Sighinolfi F; Baldini E; Puviani G; Grignaffini GF
    Riv Emoter Immunoematol; 1967; 14(5):285-90. PubMed ID: 5621349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone marrow antibodies in children with hypoplastic anemia].
    Sokolova-Akulova KG; Kalinicheva VI
    Vopr Okhr Materin Det; 1970 Oct; 15(10):30-2. PubMed ID: 5515207
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circulating inhibitor of erythropoiesis in patients with acquired aplastic anemia].
    García Y; Gudim IV; Noyola MC; Callejas RJ
    Sangre (Barc); 1984; 29(1):15-20. PubMed ID: 6719315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological studies in aplastic anemia (author's transl)].
    Yoda Y; Abe T; Komiya M
    Rinsho Ketsueki; 1976 Jun; 17(6):626-31. PubMed ID: 987289
    [No Abstract]   [Full Text] [Related]  

  • 8. [T- and B-lymphocyte content in aplastic anemia].
    Sarnitskiĭ IP; Tishchenko LM; Dadaian OA
    Vrach Delo; 1981 Jan; (1):52-5. PubMed ID: 6971016
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunohematologic studies of bone marrow in anemia].
    Siubaeva NI
    Probl Gematol Pereliv Krovi; 1967 Feb; 12(2):16-21. PubMed ID: 5620211
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological mechanisms in aplastic anemia. II. Clinical data suggesting the role of immunologic disorders in the etiology of aplastic anemia: studies in vitro].
    Rupniewska ZM; Dmoszyńska-Giannopoulos A
    Przegl Lek; 1982; 39(10):667-74. PubMed ID: 6218514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin (author's transl)].
    Silingardi V; Venezia L; Federico M; Torelli G; Salvo G
    Haematologica; 1979 Feb; 64(1):66-76. PubMed ID: 109367
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro test for detecting auto-suppressive T lymphocytes in bone marrow from patients with aplastic anemia.
    Hanada T; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):904-9. PubMed ID: 2932879
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocyte migration-inhibitory activity in serum from patients with aplastic anemia.
    Fassas A; Bruley-Rosset M
    N Engl J Med; 1979 Jan; 300(2):91-2. PubMed ID: 758585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe aplastic anemia accompanied with abnormality of T cell subset and appearance of anti-BI antibody].
    Inada T; Abe K; Imamura N; Okada K; Kuramoto A
    Rinsho Ketsueki; 1989 Aug; 30(8):1314-8. PubMed ID: 2601051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of aplastic anemia with immunosuppressive agents.
    Takaku F
    Tokai J Exp Clin Med; 1986; 11 Suppl():197-204. PubMed ID: 3452242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral immunity in aplastic anemia (author's transl)].
    Utsumi M; Ohta H; Nakamura K; Nakashima I; Yasuma A; Yamada H
    Rinsho Ketsueki; 1978 Jan; 19(1):15-21. PubMed ID: 758029
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression of natural killer cell activity in patients with aplastic anemia.
    Yagita M; Sugiyama H; Takahashi T; Imura H; Iho S; Hoshino T; Uchida A
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):893-903. PubMed ID: 4060983
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin.
    Cosimi AB; Peters C; Harmon D; Ellman L
    Transplant Proc; 1982 Dec; 14(4):761-4. PubMed ID: 6984802
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
    Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
    Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.